Literature DB >> 32554250

Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-β/CCL9 pathway.

Sheng Tian1, XiaoTong Song1, Yuan Wang1, XiaoYan Wang2, Yue Mou1, Qian Chen1, HaiJun Zhao1, Ke Ma1, ZhiChun Wu1, HuaYun Yu1, XiaoChun Han1, HuaXin Wang1, ShiJun Wang3, XuMing Ji4, YaNan Zhang5.   

Abstract

Baoyuan Jiedu (BYJD for short) decoction, a traditional Chinese medicine formula, is composed of Astragalus, Ginseng, Aconite root, Honeysuckle, Angelica, Licorice, which has the functions of nourishing qi and blood, enhancing immune function, improving quality of life and prolonging survival time of tumor patients. The present study aimed to investigate the effect and mechanism of BYJD decoction on reversing the pre-metastatic niche. We showed that BYJD decoction could prolong the survival time of 4T1 tumor-bearing mice. Moreover, we found that the BYJD decoction inhibited the formation of lung pre-metastatic niche and inhibited recruitment of myeloid derived suppressor cells (MDSCs) in the lung. Mechanistically, we showed that the proteins and genes expression of TGF-β, Smad2, Smad3, p-Smad2/3, Smad4, CCL9 in the TGF-β/CCL9 signaling pathway were suppressed by BYJD decoction. In line with the above findings, our results confirm that BYJD decoction inhibits the accumulation of MDSC in pre-metastatic niche of lung via TGF-β/CCL9 pathway.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Myeloid derived suppressor cells; Pre-metastatic niche; TGF-β/CCL9 signaling pathway; Traditional Chinese Medicine

Year:  2020        PMID: 32554250     DOI: 10.1016/j.biopha.2020.110380

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  3,3'-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells.

Authors:  Qi Sun; Lin Xiao; Zhiying Cui; Yaping Yang; Junting Ma; Zhen Huang; Junfeng Zhang; Jiangning Chen
Journal:  Chin Med       Date:  2022-06-30       Impact factor: 4.546

Review 2.  Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine.

Authors:  Chiwei Chen; Renlun Huang; Jianfu Zhou; Lang Guo; Songtao Xiang
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

Review 3.  Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.

Authors:  Liu-Cheng Li; Zhi-Hui Zhang; Wen-Cheng Zhou; Jie Chen; Hua-Qian Jin; Hong-Mei Fang; Qin Chen; Ye-Cheng Jin; Jiao Qu; Lian-Di Kan
Journal:  Biomed Pharmacother       Date:  2020-08-19       Impact factor: 6.529

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.